This is a community-generated profile. If you would like to claim it, please .

Glaukos
Develops therapies for treating glaucoma, corneal disorders, and retinal diseases501-1000 EmployeesActively Hiring
Glaukos Funding
$0
66 rounds
Glaukos is active in the following markets / industries: health care. The company has secured funding across 6 rounds and is valued at $0. Their most recent funding was raised on February 8, 2013.
Funding Rounds
U
$30000000U
$6000000U
$4500000U
$29500000D
$35000000A
$10000000Investors of Glaukos
Fjord Ventures
Montreux Equity Partners
OrbiMed
InterWest Partners
Frazier Healthcare Partners
Versant Ventures
Rounds
U
Domain Associates
Rounds
U
Founder @Seattle Angel Conference, @Dorsalfin • Worked at @Microsoft, @EMC • Studied at @Northeastern University